190 related articles for article (PubMed ID: 7959604)
1. [Measurement of fecal hemoglobin-haptoglobin complex as a new diagnostic tool of lower gastrointestinal tract diseases].
Meguro T
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):995-1009. PubMed ID: 7959604
[TBL] [Abstract][Full Text] [Related]
2. Patients with colorectal cancer are characterized by increased concentration of fecal hb-hp complex, myeloperoxidase, and secretory IgA.
Chalkias A; Nikotian G; Koutsovasilis A; Bramis J; Manouras A; Mystrioti D; Katergiannakis V
Am J Clin Oncol; 2011 Dec; 34(6):561-6. PubMed ID: 21150566
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
4. Application of fecal hemoglobin-haptoglobin complex testing for small bowel lesions.
Shiotani A; Tarumi K; Honda K; Fujita M; Matsumoto H; Manabe N; Kamada T; Hata J; Haruma K
Scand J Gastroenterol; 2014 May; 49(5):539-44. PubMed ID: 24621414
[TBL] [Abstract][Full Text] [Related]
5. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
[TBL] [Abstract][Full Text] [Related]
6. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937
[TBL] [Abstract][Full Text] [Related]
7. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
[TBL] [Abstract][Full Text] [Related]
8. Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB).
Syrjänen K; Eskelinen M; Meklin J; Hendolin P; Eskelinen M; Suovaniemi O
Anticancer Res; 2024 Apr; 44(4):1513-1523. PubMed ID: 38537972
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.
Kim Y; Lee S; Park S; Jeon H; Lee W; Kim JK; Cho M; Kim M; Lim J; Kang CS; Han K
Ann Clin Lab Sci; 2003; 33(1):32-8. PubMed ID: 12661896
[TBL] [Abstract][Full Text] [Related]
10. The Automatically Analyzed (AA) ColonView (CV) Quick Test for Fecal Occult Blood Shows Higher Diagnostic Accuracy in Detection of Colorectal Adenoma than Visually Analyzed Tests.
Meklin J; Eskelinen M; Guimaraes DP; Selander T; Tiusanen T; Syrjänen K; Eskelinen M
Anticancer Res; 2021 Nov; 41(11):5517-5525. PubMed ID: 34732422
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.
Limburg PJ; Devens ME; Harrington JJ; Diehl NN; Mahoney DW; Ahlquist DA
Am J Gastroenterol; 2003 Oct; 98(10):2299-305. PubMed ID: 14572583
[TBL] [Abstract][Full Text] [Related]
12. Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces.
Sieg A; Thoms C; Lüthgens K; John MR; Schmidt-Gayk H
Int J Colorectal Dis; 1999 Dec; 14(6):267-71. PubMed ID: 10663892
[TBL] [Abstract][Full Text] [Related]
13. Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial.
van Roon AH; Hol L; van Vuuren AJ; Francke J; Ouwendijk M; Heijens A; Nagtzaam N; Reijerink JC; van der Togt AC; van Ballegooijen M; Kuipers EJ; van Leerdam ME
Am J Gastroenterol; 2012 Jan; 107(1):99-107. PubMed ID: 22108450
[TBL] [Abstract][Full Text] [Related]
14. A new approach to fecal occult blood testing based on the detection of haptoglobin.
Xing PX; Young GP; Ho D; Sinatra MA; Hoj PB; McKenzie IF
Cancer; 1996 Jul; 78(1):48-56. PubMed ID: 8646726
[TBL] [Abstract][Full Text] [Related]
15. Immunological determination of fecal hemoglobin and transferrin levels: a comparison with other fecal occult blood tests.
Miyoshi H; Ohshiba S; Asada S; Hirata I; Uchida K
Am J Gastroenterol; 1992 Jan; 87(1):67-73. PubMed ID: 1728128
[TBL] [Abstract][Full Text] [Related]
16. Rapid fecal cytokeratin-19 test and fecal occult blood test in screening for gastrointestinal diseases.
Kim H; Kim Y; Yoon S; Lim J; Kim M; Lee S; Kang S; Lee EJ; Kang CS; Han K
Ann Clin Lab Sci; 2006; 36(3):294-8. PubMed ID: 16951270
[TBL] [Abstract][Full Text] [Related]
17. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
18. A new immunological test strip device for the rapid, qualitative detection of faecal occult blood.
Trojan J; Povse N; Schröder O; Stein J
Z Gastroenterol; 2002 Nov; 40(11):921-4. PubMed ID: 12436369
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of fecal occult blood tests for early detection of gastrointestinal pathology.
Stelling HP; Maimon HN; Smith RA; Haddy RI; Markert RJ
Arch Intern Med; 1990 May; 150(5):1001-5. PubMed ID: 2331181
[TBL] [Abstract][Full Text] [Related]
20. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
